Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bayer wins key FDA approval for lung disease drug Adempas
Bayer wins key FDA approval for lung disease drug Adempas
Bayer wins key FDA approval for lung disease drug Adempas
Submitted by
admin
on October 9, 2013 - 10:13am
Source:
Fierce Biotech
News Tags:
Adempas
Bayer
FDA
Riociguat
thromboembolic pulmonary hypertension
Headline:
Bayer wins key FDA approval for lung disease drug Adempas
Do Not Allow Advertisers to Use My Personal information
